{"id":"NCT00260832","sponsor":"Eisai Inc.","briefTitle":"Trial of Decitabine in Patients With Acute Myeloid Leukemia","officialTitle":"Randomized Phase 3 Trial of Decitabine Versus Patient's Choice With Physician's Advice of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-11","primaryCompletion":"2009-10","completion":"2010-12","firstPosted":"2005-12-02","resultsPosted":"2011-09-21","lastUpdate":"2019-09-11"},"enrollment":485,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Myeloid Leukemia"],"interventions":[{"type":"DRUG","name":"Cytarabine or Supportive Care","otherNames":[]},{"type":"DRUG","name":"Dacogen (decitabine) only","otherNames":["decitabine"]}],"arms":[{"label":"A","type":"EXPERIMENTAL"},{"label":"B","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the results in older patients who have newly diagnosed or secondary acute myeloid leukemia (AML) and who are to either receive decitabine or patient's choice with the physician's advice of either cytarabine or supportive care medication.","primaryOutcome":{"measure":"Overall Survival in Patients 65 Years or Older Who Have Newly Diagnosed de Novo or Secondary AML.","timeFrame":"The interval from date of randomization to the date of death from any cause or the last date the subject was known to be alive or 5 years whichever occurs first.","effectByArm":[{"arm":"Cytarabine or Supportive Care","deltaMin":5,"sd":null},{"arm":"Dacogen (Decitabine) Only","deltaMin":7.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1079"}]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":108,"countries":["United States","Australia","Canada","Croatia","Czechia","France","Hungary","Mexico","Poland","Romania","Russia","Serbia","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["24498872"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":162,"n":237},"commonTop":["Pyrexia","Thrombocytopenia","Anemia","Febrile Neutropenia","Disease Progression"]}}